Who is sponsoring NCT05742659?

NCT05742659 is sponsored by National Cheng-Kung University Hospital.

What drugs are being tested in NCT05742659?

Interventions in NCT05742659: A mobile-based interactive simulation scheme (MISS).

What condition does NCT05742659 study?

NCT05742659 studies Nasogastric Tube Insertion.

Is NCT05742659 still recruiting?

NCT05742659 is currently completed. Last updated 24 February 2023.

Last reviewed 2023-02-24 · How we verify

NCT05742659

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of Developing a Mobile-based Interactive Simulation Scheme for Assisting the Personalized Hands-on Learning of Nasogastric Tube Insertion

Completed NA Last updated 24 February 2023

What this trial tests

NA trial testing A mobile-based interactive simulation scheme (MISS) in Nasogastric Tube Insertion in 73 participants. Completed in 20 May 2021.

Timeline

17 August 2020

Primary endpoint
17 October 2020

20 May 2021

Quick facts

Lead sponsor	National Cheng-Kung University Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	other
Enrollment	73
Start date	17 August 2020
Primary completion	17 October 2020
Estimated completion	20 May 2021
Sites	1 location across Taiwan

Drugs / interventions tested

A mobile-based interactive simulation scheme (MISS)

Conditions studied

Nasogastric Tube Insertion — all drugs for Nasogastric Tube Insertion →

Sponsor

National Cheng-Kung University Hospital

Who can join

20 and older, any sex, with Nasogastric Tube Insertion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A mobile-based interactive simulation scheme (MISS) was proposed and developed to investigate its effects on facilitating hands-on learning of nasogastric tube insertion in undergraduate medical students.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effectiveness of Mobile-Based Learning for Nasogastric Tube Intubation Among Medical Students: A Randomized Controlled Trial.
Wu MH, Chen CJ, Lee HF. · · 2025 · PMID 40077108 · DOI 10.3390/healthcare13050546

Verify or expand the search:

Other National Cheng-Kung University Hospital trials

Trials by the same sponsor.

NCT07525713 — Virtual Reality Mirror Therapy With Focused Object-Directed Attention System · NA · not yet recruiting
NCT07369271 — Continuous Cervical Erector Spinae Plane Block Versus Interscalene Nerve Block in Shoulder Arthroscopic Surgery · NA · not yet recruiting
NCT07262411 — Peer-based Recovery Program · NA · not yet recruiting
NCT07257926 — Prevention of Delayed Post-polypectomy Bleeding by Endoscopic Sucralfate Spray in High-risk Patients: A Randomized Contr · Phase 4 · not yet recruiting
NCT07269132 — Applying the ADDIE Model to Develop a Multimedia Program to Enhance Chemotherapy Knowledge and Self-Efficacy Among Inten · NA · enrolling by invitation

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05742659 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by National Cheng-Kung University Hospital
Last refreshed: 24 February 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05742659.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing